Evidence map›Paper›PMID 35799130›Full record

ArticleBMC infectious diseases2022

Genomic surveillance for multidrug-resistant or hypervirulent Klebsiella pneumoniae among United States bloodstream isolates.

Travis J Kochan, Sophia H Nozick, Rachel L Medernach, Bettina H Cheung, Samuel W M Gatesy, Marine Lebrun-Corbin, Sumitra D Mitra, Natalia Khalatyan, Fiorella Krapp, Chao Qi and 2 more

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed, 1 pooled it
5.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 1 synthesis or guideline pooled it, 84 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. HypervirulentOpen forum infectious diseases · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Connections betweenInfection and immunity · 2026
    Article
  10. Article
  11. The acquisition ofmBio · 2026
    Article
  12. Article
  13. Variable progressive behavior ofFrontiers in immunology · 2026
    Article
  14. Article
  15. Genomic characterization ofFrontiers in microbiology · 2026
    Article
  16. Modulation of macrophage survival duringFrontiers in cellular and infection microbiology · 2026
    Review
  17. Article
  18. Parallel single-cell host immune profiling and pathogen genomic characterization inFrontiers in cellular and infection microbiology · 2026
    Observational
  19. Regional surveillance of carbapenem-resistantFrontiers in cellular and infection microbiology · 2026
    Article
  20. Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Travis J KochanDepartment of Microbiology-Immunology, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA. Travis.Kochan@northwestern.edu.ORCID https://orcid.org/0000-0002-7560-8550
Sophia H NozickDepartment of Microbiology-Immunology, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA.
Rachel L MedernachDepartment of Microbiology-Immunology, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA.
Bettina H CheungDepartment of Microbiology-Immunology, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA.
Samuel W M GatesyDivision of Infectious Diseases, Department of Medicine, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA.
Marine Lebrun-CorbinDepartment of Microbiology-Immunology, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA.
Sumitra D MitraDepartment of Microbiology-Immunology, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA.
Natalia KhalatyanDepartment of Microbiology-Immunology, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA.
Fiorella KrappDivision of Infectious Diseases, Department of Medicine, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA.
Chao QiDepartment of Pathology, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA.
Egon A OzerDivision of Infectious Diseases, Department of Medicine, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA.
Alan R HauserDepartment of Microbiology-Immunology, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA.
Northwestern University · US

Funding

Northwestern University Clinical and Translational Science Institute (NUCATS)UL1TR001422 · NCATS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI D'AQUILA, RICHARD · 2015 to 2023
$56.8M
TRAINING PROGRAM IN IMMUNOLOGY &MOLECULAR PATHOGENESIST32AI007476 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Edward Benjamin Thorp · 1996 to 2026
$6.6M
Population Analysis of Pseudomonas aeruginosa VirulenceR01AI118257 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI HAUSER, ALAN R · 2016 to 2025
$4.9M
Translational Research Training in Infectious DiseasesT32AI095207 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Claudia A Hawkins, Jennie H Kwon · 2012 to 2026
$2.2M
Patient-Oriented Research on Pseudomonas aeruginosaK24AI104831 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI HAUSER, ALAN R · 2013 to 2024
$1.2M
Dynamics of Pseudomonas aeruginosa During BacteremiaR21AI153953 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI HAUSER, ALAN R · 2020 to 2021
$435k
High-Risk Clones of Pseudomonas aeruginosaR21AI164254 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI HAUSER, ALAN R · 2021 to 2022
$431k
NCATS NIH HHS UL1 TR001422NIAID NIH HHS K24 AI104831NIAID NIH HHS R01 AI118257NIAID NIH HHS R21 AI153953NIAID NIH HHS R21 AI164254NIAID NIH HHS T32 AI007476NIAID NIH HHS T32 AI095207
6 · The paper itself

Abstract

backgroundKlebsiella pneumoniae strains have been divided into two major categories: classical K. pneumoniae, which are frequently multidrug-resistant and cause hospital-acquired infections in patients with impaired defenses, and hypervirulent K. pneumoniae, which cause severe community-acquired and disseminated infections in normal hosts. Both types of infections may lead to bacteremia and are associated with significant morbidity and mortality. The relative burden of these two types of K. pneumoniae among bloodstream isolates within the United States is not well understood.

methodsWe evaluated consecutive K. pneumoniae isolates cultured from the blood of hospitalized patients at Northwestern Memorial Hospital (NMH) in Chicago, Illinois between April 2015 and April 2017. Bloodstream isolates underwent whole genome sequencing, and sequence types (STs), capsule loci (KLs), virulence genes, and antimicrobial resistance genes were identified in the genomes using the bioinformatic tools Kleborate and Kaptive. Patient demographic, comorbidity, and infection information, as well as the phenotypic antimicrobial resistance of the isolates were extracted from the electronic health record. Candidate hypervirulent isolates were tested in a murine model of pneumonia, and their plasmids were characterized using long-read sequencing. We also extracted STs, KLs, and virulence and antimicrobial resistance genes from the genomes of bloodstream isolates submitted from 33 United States institutions between 2007 and 2021 to the National Center for Biotechnology Information (NCBI) database.

resultsConsecutive K. pneumoniae bloodstream isolates (n = 104, one per patient) from NMH consisted of 75 distinct STs and 51 unique capsule loci. The majority of these isolates (n = 58, 55.8%) were susceptible to all tested antibiotics except ampicillin, but 17 (16.3%) were multidrug-resistant. A total of 32 (30.8%) of these isolates were STs of known high-risk clones, including ST258 and ST45. In particular, 18 (17.3%) were resistant to ceftriaxone (of which 17 harbored extended-spectrum beta-lactamase genes) and 9 (8.7%) were resistant to meropenem (all of which harbored a carbapenemase genes). Four (3.8%) of the 104 isolates were hypervirulent K. pneumoniae, as evidenced by hypermucoviscous phenotypes, high levels of virulence in a murine model of pneumonia, and the presence of large plasmids similar to characterized hypervirulence plasmids. These isolates were cultured from patients who had not recently traveled to Asia. Two of these hypervirulent isolates belonged to the well characterized ST23 lineage and one to the re-emerging ST66 lineage. Of particular concern, two of these isolates contained plasmids with tra conjugation loci suggesting the potential for transmission. We also analyzed 963 publicly available genomes of K. pneumoniae bloodstream isolates from locations within the United States. Of these, 465 (48.3%) and 760 (78.9%) contained extended-spectrum beta-lactamase genes or carbapenemase genes, respectively, suggesting a bias towards submission of antibiotic-resistant isolates. The known multidrug-resistant high-risk clones ST258 and ST307 were the predominant sequence types. A total of 32 (3.3%) of these isolates contained aerobactin biosynthesis genes and 26 (2.7%) contained at least two genetic features of hvKP strains, suggesting elevated levels of virulence. We identified 6 (0.6%) isolates that were STs associated with hvKP: ST23 (n = 4), ST380 (n = 1), and ST65 (n = 1).

conclusionsExamination of consecutive isolates from a single center demonstrated that multidrug-resistant high-risk clones are indeed common, but a small number of hypervirulent K. pneumoniae isolates were also observed in patients with no recent travel history to Asia, suggesting that these isolates are undergoing community spread in the United States. A larger collection of publicly available bloodstream isolate genomes also suggested that hypervirulent K. pneumoniae strains are present but rare in the USA; however, this collection appears to be heavily biased towards highly antibiotic-resistant isolates (and correspondingly away from hypervirulent isolates).

Indexed as

Anti-Bacterial AgentsDrug Resistance, Multiple, BacterialKlebsiella InfectionsKlebsiella pneumoniaeAnimalsbeta-LactamasesDisease Models, AnimalGenomicsHumansMiceSepsisUnited StatesAnti-Bacterial Agentsbeta-LactamasesBacteremiaHypervirulent KlebsiellaKlebsiella pneumoniaePathogenesisWhole-genome sequencing

Identifiers

PMID35799130
PMCPMC9263067
OpenAlexW4284897167

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.